org placeholder image

Bunmi Shola

Clinical Trial Manager at CRISPR Therapeutics

  • LinkedIn

Email Email: b****@crisprtx.com

phone noPhone Number: (***)-***-****

map
CRISPR THERAPEUTICS

CRISPR THERAPEUTICS

  • description Description
    CRISPR Therapeutics is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. CRISPR/Cas9 is...

    Read More

  • Employees count Employees 201-500
  • Revenue Revenue 100 Million to 250 Million
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

CRISPR Therapeutics Org Chart and Mapping

Employees

Michelle Mu

Research Associate II

Julia Shannon

Senior Research Associate

Daniel Henderson

Senior Research Associate

Kamilla Fellah

Research Operations Manager

Paul Sullivan

Senior Director of Market Access

Kerri Mosher

Infusion Nurse Expert, Sr Manager for Cell Therapy Support Operations

Apoorva Muttagi

Principal Research Associate

Frequently Asked Questions Regarding Bunmi Shola

Answer: Bunmi Shola works for CRISPR Therapeutics as Clinical Trial Manager

Answer: Bunmi Shola’s role in CRISPR Therapeutics is Clinical Trial Manager

Answer: Bunmi Shola's email address is b***@gmail.com

Answer: Bunmi Shola's business email address is b****@crisprtx.com

Answer: Bunmi Shola’s direct phone number is (***)-***-****

Answer: Bunmi Shola works in the industry of: Biotechnology

Answer: Bunmi Shola works CRISPR Therapeutics located at 828 Winter St, Boston, Massachusetts, 02451, United States

Answer: CRISPR Therapeutics's Clinical Trial Manager is Bunmi Shola

Answer: Bunmi Shola contact details:

  • Phone number  :  (***)-***-****
  • Email  :  b****@crisprtx.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access